FDA Approved: AUVELITY — Original Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

AUVELITY is FDA-approved as a fixed-dose combination of dextromethorphan hydrobromide and bupropion hydrochloride for the treatment of adults with major depress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• AUVELITY (Dextromethorphan hydrobromide, bupropion hydrochloride)

Snippet

ORIG AP for AUVELITY (DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE)